GlycoMimetics Inc
(FRA:GKO)
€
0.2305
0.011 (5.01%)
Market Cap: 15.84 Mil
Enterprise Value: -12.79 Mil
PE Ratio: 0
PB Ratio: 0.59
GF Score: 30/100 - Q4 2023 GlycoMimetics Inc Earnings Call TranscriptMar 27, 2024€2.85 (+11.33%)Earnings
- Q3 2023 GlycoMimetics Inc Earnings Call TranscriptNov 03, 2023€1.2 (+0.67%)Earnings
- Q2 2023 GlycoMimetics Inc Earnings Call TranscriptAug 02, 2023€1.48Earnings
- GlycoMimetics Inc at Jefferies Healthcare Conference TranscriptJun 07, 2023
- Q1 2023 GlycoMimetics Inc Earnings Call TranscriptMay 03, 2023€1.25 (-3.25%)Earnings
- Q4 2022 GlycoMimetics Inc Earnings Call TranscriptMar 29, 2023€1.28 (-0.19%)Earnings
- Q3 2022 GlycoMimetics Inc Earnings Call TranscriptNov 09, 2022€0.6596 (-1.11%)Earnings
- Q2 2022 GlycoMimetics Inc Earnings Call TranscriptAug 03, 2022€0.6544 (+2.15%)Earnings
- Q1 2022 GlycoMimetics Inc Earnings Call TranscriptApr 28, 2022€0.7966 (-3.28%)Earnings
- Q4 2021 GlycoMimetics Inc Earnings Call TranscriptMar 03, 2022€1.07 (-9.32%)Earnings
- Q3 2021 GlycoMimetics Inc Earnings Call TranscriptNov 02, 2021€1.75 (+3.55%)Earnings
- Q2 2021 GlycoMimetics Inc Earnings Call TranscriptAug 05, 2021€1.65 (-2.37%)Earnings
- GlycoMimetics Inc Annual Shareholders Meeting TranscriptMay 18, 2021
- Q1 2021 GlycoMimetics Inc Earnings Call TranscriptMay 03, 2021€1.97 (-7.08%)Earnings
- Q4 2020 GlycoMimetics Inc Earnings Call TranscriptMar 02, 2021€2.92 (+4.29%)Earnings
- GlycoMimetics Inc at Jefferies Virtual London Healthcare Conference TranscriptNov 19, 2020
- GlycoMimetics Inc at Stifel Virtual Healthcare Conference TranscriptNov 17, 2020
- Q3 2020 GlycoMimetics Inc Earnings Call TranscriptNov 06, 2020€2.54 (+1.60%)Earnings
- Q2 2020 GlycoMimetics Inc Earnings Call TranscriptJul 31, 2020€3.5 (-0.57%)Earnings
- GlycoMimetics Inc Annual Shareholders Meeting TranscriptMay 22, 2020
- Q1 2020 GlycoMimetics Inc Earnings Call TranscriptMay 01, 2020€2.48Earnings
- Q4 2019 GlycoMimetics Inc Earnings Call TranscriptFeb 28, 2020€3.36 (+2.44%)Earnings
- Q3 2019 GlycoMimetics Inc Earnings Call TranscriptNov 07, 2019€5.05 (-2.88%)Earnings
- GlycoMimetics Inc at Morgan Stanley Healthcare Conference TranscriptSep 11, 2019
- Q2 2019 GlycoMimetics Inc Earnings Call TranscriptAug 01, 2019€8.19 (+0.86%)Earnings
- Q1 2019 GlycoMimetics Inc Earnings Call TranscriptMay 02, 2019€10.35 (-5.82%)Earnings
- Q4 2018 GlycoMimetics Inc Earnings Call TranscriptMar 06, 2019€10.17 (-2.21%)Earnings
GlycoMimetics Inc at Stifel Virtual Healthcare Conference Transcript
Nov 17, 2020 / 01:00PM GMT
Release Date Price:
€3.1
(+5.44%)
Operator
My name is Ellen Sands, and I'm a biotechnology associate at Stifel. And today, I have the pleasure of speaking with Rachel King, the CEO of GlycoMimetics. (Operator Instructions)
So Rachel, thanks for being here today, and...
Rachel K. King
GlycoMimetics, Inc. - President, CEO & Director
Sure.
Ellen Sands
Stifel, Nicolaus & Company, Incorporated, Research Division - Research Analyst
And maybe to start, you can give a brief overview of GlycoMimetics and just touch on the pipeline at a high level, and then we can dive in after that.
Rachel K. King
GlycoMimetics, Inc. - President, CEO & Director
Sure. So we're a clinical stage company. We've got a late-stage program now in AML, which is in 2 Phase III registration trials, one is treating newly diagnosed patients who are fit for chemotherapy, and the other treating relapsed/refractory patients also fit for chemotherapy. That's our most advanced program.
We also have a program that recently
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
![](https://static.gurufocus.com/material/money-back-guarantee.png)
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent ![](https://static.gurufocus.com/trust_rating.png)
![](https://static.gurufocus.com/trust_rating.png)
4.6 out of 5
Trustpilot
![](https://static.gurufocus.com/trust.png)